Previous studies have shown that the positive-feedback loop initiated by the C-X-C chemokine receptor type 4 (CXCR4), highly expressed in malignant BCCs, to the CXCL12 expressed in bone lead to breast cancer migration33,34. Here, CXCL12 is linked to breast cancer.